Empresa Ophthotech Corp Nasdaq
Acciones
US6837451037
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 01/07/13 |
Mark Reisenauer
PSD | President | 58 | 11/07/23 |
Xiao Ping Dai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Keith Westby
COO | Chief Operating Officer | 49 | 29/01/17 |
Evelyn Harrison
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/07 |
Kathy Galante
IRC | Investor Relations Contact | - | 13/11/13 |
Corporate Officer/Principal | 49 | 02/08/21 | |
Julie Clark
PRN | Corporate Officer/Principal | - | - |
Amy Sheehan
HRO | Human Resources Officer | - | 01/01/14 |
Dhaval Desai
PRN | Corporate Officer/Principal | - | 01/01/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 01/07/13 |
Mark Reisenauer
PSD | President | 58 | 11/07/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 137 976 851 | 137 657 408 ( 99,77 %) | 0 | 99,77 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+0,67 % | 42,4 mil M | |
+45,89 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+6,55 % | 24,94 mil M | |
-21,66 % | 18,96 mil M | |
+29,96 % | 12,3 mil M | |
-1,57 % | 11,95 mil M | |
+16,03 % | 11,32 mil M | |
-4,80 % | 11,55 mil M |